Radiation Therapy Dose for the Treatment of Patients With Lung Cancer
Walter J. Curran, Jr., MD, FACR, associate vice president of cancer, Woodruff Health Sciences Center, executive director, Winship Cancer Institute, Lawrence W. Davis Chair of Radiation Oncology, Emory University, discusses radiation therapy dose for the treatment of patients with lung cancer.
Curran explains how patients were randomized between standard dose radiation and a dose 22% higher. He and his team hoped for a survival improvement with the group of patients receiving the higher dose. However, it was found that the latter group was associated with a worse survival than the group receiving the standard dose.
The results led Curran and his colleagues to further consider planning the delivery of radiation and conduct future trials.
Walter J. Curran, Jr., MD, FACR, associate vice president of cancer, Woodruff Health Sciences Center, executive director, Winship Cancer Institute, Lawrence W. Davis Chair of Radiation Oncology, Emory University, discusses radiation therapy dose for the treatment of patients with lung cancer.
Gholam Contrasts Lenvatinib With Other Options in Child-Pugh B HCC
December 21st 2024During a Case-Based Roundtable® event, Pierre Gholam, MD, discussed how post hoc and real-world analyses build upon the limited available trial data for treating patients with unresectable hepatocellular carcinoma with Child-Pugh B status.
Read More
